|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 444.00 INR | -0.96% |
|
-0.61% | +0.68% |
| 05-22 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 20.68B 219M 191M 176M 166M 310M 312M 2.1B 814M 10.19B 824M 806M 35.33B | P/E 2024 |
-48.8x | P/E 2025 | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38B 259M 225M 208M 195M 366M 368M 2.47B 960M 12.02B 971M 950M 41.65B | EV / Sales 2024 |
2.07x | EV / Sales 2025 | 2.49x |
| Free-Float |
28.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.77% | ||
| 1 week | -0.61% | ||
| Current month | +27.34% | ||
| 1 month | +19.17% | ||
| 3 months | +43.20% | ||
| 6 months | -1.10% | ||
| Current year | +0.68% |
| 1 week | 426.7 |  | 467.9 |
| 1 month | 339.5 | | 515.95 |
| Current year | 278.2 | | 515.95 |
| 1 year | 278.2 | | 657.95 |
| 3 years | 278.2 | | 937.95 |
| 5 years | 198 | | 937.95 |
| 10 years | 80 | | 937.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | -0.61% | - | - | 336M | |
| -1.21% | -5.37% | +39.94% | +145.38% | 992B | |
| -2.48% | -4.17% | +51.52% | +39.07% | 564B | |
| -2.14% | -3.68% | +16.71% | +56.15% | 391B | |
| -1.18% | +0.25% | +25.86% | +16.53% | 330B | |
| -2.36% | -3.12% | +24.71% | +11.59% | 280B | |
| -2.45% | -2.88% | +24.29% | +30.06% | 279B | |
| -1.91% | -0.87% | -41.95% | -49.25% | 196B | |
| -1.19% | -4.65% | +16.56% | +47.00% | 184B | |
| -1.35% | -1.68% | +14.59% | +56.94% | 156B | |
| Average | -1.70% | -1.98% | +19.14% | +39.27% | 374.58B | |
| Weighted average by Cap. | -1.77% | -2.88% | +28.03% | +63.21% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.05B 181M 158M 145M 137M 256M 257M 1.73B 671M 8.4B 679M 664M 29.12B | 21.11B 224M 195M 180M 169M 317M 319M 2.14B 831M 10.4B 841M 823M 36.06B |
| Net income | -705M -7.48M -6.52M -6.01M -5.65M -10.57M -10.64M -71.46M -27.75M -347M -28.07M -27.47M -1.2B | 1.38B 14.59M 12.71M 11.72M 11.02M 20.62M 20.77M 139M 54.15M 678M 54.77M 53.6M 2.35B |
| Net Debt | 953M 10.11M 8.81M 8.12M 7.64M 14.29M 14.39M 96.59M 37.51M 469M 37.94M 37.13M 1.63B | 3.7B 39.28M 34.22M 31.55M 29.67M 55.52M 55.91M 375M 146M 1.82B 147M 144M 6.32B |
Employees
3,142
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/06/26 | 444.00 ₹ | -0.96% | 7,973 |
| 18/06/26 | 448.30 ₹ | -0.26% | 161,656 |
| 17/06/26 | 449.45 ₹ | +0.69% | 393,603 |
| 16/06/26 | 446.35 ₹ | +1.45% | 803,265 |
| 15/06/26 | 439.95 ₹ | -1.71% | 603,085 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
